Gestione del paziente con microcitoma nelle regioni Lazio, Umbria e Sardegna

Translated title of the contribution: Management of small cell lung cancer patient in the regions of Lazio, Umbria and Sardinia

Gabriele Minuti, Alessio Stefani, Silvia Carpano, Ettore D'Argento, Raffaele Giusti, Olga Martelli, Giulio Metro, Alain J. Gelibter, Gian Carlo Antonini Cappellini, Annamaria Carta, Giovanni Maria Fadda, Fabrizio Nelli, Serena Ricciardi, Marco Russano, Emilio Bria, Federico Cappuzzo

Research output: Contribution to journalArticlepeer-review

Abstract

Small cell lung cancer (SCLC) is an aggressive disease, difficult to treat. There have been no significant therapeutic advances over platinum and etoposide chemotherapy in the last 20 years until the introduction of immunotherapy. In 2020 atezolizumab, an immune checkpoint inhibitor against PD-L1 was approved in Italy in combination with carboplatin and etoposide for the first-line treatment of patients with extensive stage disease (ES-SCLC), becoming the new standard treatment. On May 20, 2021, a virtual meeting, directed by profs. Federico Cappuzzo and Emilio Bria, was held in which 14 clinicians from different oncology centers in Lazio, Umbria and Sardinia discussed the issues of ES-SCLC patients treatment, after the advent of immunotherapy. The aim of the meeting was to share their clinical experience and to provide a series of practical indications that can support clinicians in the management of ES-SCLC patients in first-line with chemo-immunotherapy.

Translated title of the contributionManagement of small cell lung cancer patient in the regions of Lazio, Umbria and Sardinia
Original languageItalian
Pages (from-to)639-646
Number of pages8
JournalRecenti Progressi in Medicina
Volume112
Issue number10
DOIs
Publication statusPublished - Oct 2021

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Management of small cell lung cancer patient in the regions of Lazio, Umbria and Sardinia'. Together they form a unique fingerprint.

Cite this